Transaction #11995 · Form 4 · 0001213900-25-113841
Turn Therapeutics Inc. · Purchase · Common Stock
Turn Therapeutics Inc. · Transacted November 21, 2025 · Filed November 24, 2025
What does this filing report?
An SEC Form 4 filing for Turn Therapeutics Inc. records a purchase involving Common Stock on November 21, 2025. The reported quantity was 20,532. The filing date is November 24, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Turn Therapeutics Inc.
- Company CIK
- 0002023016
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 20,532
- Reported price
- 2.87 · See footnotes
- Reference value
- 58,926.84
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 50,734
- Ownership description
- Not reported
- SEC acceptance time
- Nov 24, 2025, 7:13 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- GOLDEN ARTHUR F ↗
Director
CIK 0001023260
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Certain of the securities reported in Column 5 of Table I are restricted stock units ("RSUs") granted under the Issuer's 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and the reporting person's continuous service through the vesting date.
- F2
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $3.25, inclusive. The Reporting Person undertakes to provide to Turn Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.